Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey

Open access
Landgren, O, Graubard, B I, Katzmann, J A, Kyle, R A, Ahmadizadeh, I, Clark, R, Kumar, S K, Dispenzieri, A, Greenberg, A J, Therneau, T M, Melton, L J, Caporaso, N, Korde, N, Roschewski, M, Costello, R, McQuillan, G M, Rajkumar, S V · 2014 · Leukemia

Abstract

Multiple myeloma (MM) incidence is markedly higher in blacks compared with whites, which may be related to a higher prevalence of monoclonal gammopathy of undetermined significance (MGUS). Our objective was to define the prevalence and risk factors of MGUS in a large cohort representative of the US population. Stored serum samples from the National Health and Nutritional Examination Survey (NHANES) III or NHANES 1999–2004 were available for 12 482 individuals of age ⩾50 years (2331 ‘blacks’, 2475 Hispanics, 7051 ‘whites’ and 625 ‘others’) on which agarose-gel electrophoresis, serum protein immunofixation, serum-free light-chain assay and M-protein typing were performed. MGUS was identified in 365 participants (2.4%). Adjusted prevalence of MGUS was significantly higher (P<0.001) in blacks (3.7%) compared with whites (2.3%) (P=0.001) or Hispanics (1.8%), as were characteristics that posed a greater risk of progression to MM. The adjusted prevalence of MGUS was 3.1% and 2.1% for the North/Midwest versus South/West regions of the United States, respectively (P=0.052). MGUS is significantly more common in blacks, and more often has features associated with higher risk of progression to MM. A strong geographic disparity in the prevalence of MGUS between the North/Midwest versus the South/West regions of the United States was found, which has etiologic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2014.34

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 29

  1. Kyle RA, Rajkumar SV . Multiple myeloma. N Engl J Med 2004; 351: 1860–1873. · DOI · Paper page
  2. Rajkumar SV . Treatment of multiple myeloma. Nat Rev Clin Oncol 2011; 8: 479–491. · DOI · Paper page
  3. Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM . A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009; 113: 5418–5422. · DOI · Paper page
  4. Kyle RA, Rajkumar SV . Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3–9. · DOI · Paper page
  5. Rajkumar SV, Kyle RA, Therneau TM, Melton LJ III, Bradwell AR, Clark RJ et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS). Blood 2005; 106: 812–817. · DOI · Paper page
  6. Greenberg AJ, Vachon CM, Rajkumar SV . Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia 2012; 26: 609–614. · DOI
  7. Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 2010; 116: 5501–5506. · DOI · Paper page
  8. Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS . Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med 1998; 104: 439–444. · DOI · Paper page
  9. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006; 107: 904–906. · DOI · Paper page
  10. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR . Sample design: third National Health and Nutrition Examination Survey. Vital Health Stat 2 1992; 13: 1–35.
  11. Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB et al. The National Health and Nutrition Examination Survey: Sample design, 1999-2006. Vital Health Stat 2 2012; 155: 1–39.
  12. Korn EL, Graubard BI . Analysis of Health Survey. Wiley: New York, NY, 1999. · DOI · Paper page
  13. Durrleman S, Simon R . Flexible regression models with cubic splines. Stat Med 1989; 8: 551–561. · DOI · Paper page
  14. Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance (MGUS) among African-American and Caucasian women. Blood 2010; 116: 1056–1059. · DOI · Paper page
  15. Blair CK, Cerhan JR, Folsom AR, Ross JA . Anthropometric characteristics and risk of multiple myeloma. Epidemiology 2005; 16: 691–694. · DOI
  16. Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A et al. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 2008; 93: 1666–1677. · DOI
  17. Baris D, Brown LM, Silverman DT, Hayes R, Hoover RN, Swanson GM et al. Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 2000; 90: 1277–1281. · DOI
  18. Boffetta P, Stellman SD, Garfinkel L . A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 1989; 43: 554–559. · DOI
  19. Koessel SL, Theis MK, Vaughan TL, Koepsell TD, Weiss NS, Greenberg RS et al. Socioeconomic status and the incidence of multiple myeloma. Epidemiology 1996; 7: 4–8. · doi:10.1097/00001648-199601000-00002
  20. Landgren O . Sun, mother of life, prevents cancer. Blood 2011; 118: 1431–1432. · doi:10.1182/blood-2011-06-359794
  21. Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L et al. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood 2011; 118: 1591–1599. · DOI
  22. Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance (MGUS) in the Agricultural Health Study. Blood 2009; 25: 6386–6391. · DOI · Paper page
  23. Alavanja MC, Sandler DP, Lynch CF, Knott C, Lubin JH, Tarone R et al. Cancer incidence in the agricultural health study. Scand J Work Environ Health 2005; 31: 39–45, discussion 35-37.
  24. Landgren O, Katzmann JA, Hsing AW, Pfeiffer RM, Kyle RA, Yeboah ED et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007; 82: 1468–1473. · DOI · Paper page
  25. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975-2005, based on November 2007 SEER data submission. National Cancer Institute: Bethesda, MD, 2008.
  26. Kristinsson SY, Goldin LR, Bjorkholm M, Koshiol J, Turesson I, Landgren O . Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica 2009; 94: 1581–1589. · DOI
  27. Brown LM, Gridley G, Check D, Landgren O . Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388–3394. · DOI · Paper page
  28. Eriksson M . Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 1993; 29A: 259–263. · doi:10.1016/0959-8049(93)90188-l
  29. Hakulinen T, Isomaki H, Knekt P . Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985; 78: 29–32. · doi:10.1016/0002-9343(85)90242-6

Cited by

See all 208

Metadata

Authors
Landgren, O., Graubard, B. I., Katzmann, J. A., Kyle, R. A., Ahmadizadeh, I., Clark, R., Kumar, S. K., Dispenzieri, A., Greenberg, A. J., Therneau, T. M., Melton, L. J., Caporaso, N., Korde, N., Roschewski, M., Costello, R., McQuillan, G. M., & Rajkumar, S. V.
Venue
Leukemia
Published
2014-01-20
Volume
28
Issue
7
Pages
1537-1542
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2027698431
Cited by
208
References
5
FWCI
8.98
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey. https://app.cochat.ai/papers/10.1038/leu.2014.34
The paper
Landgren, O., Graubard, B. I., Katzmann, J. A., Kyle, R. A., Ahmadizadeh, I., Clark, R., Kumar, S. K., Dispenzieri, A., Greenberg, A. J., Therneau, T. M., Melton, L. J., Caporaso, N., Korde, N., Roschewski, M., Costello, R., McQuillan, G. M., & Rajkumar, S. V. (2014). Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey. Leukemia. https://doi.org/10.1038/leu.2014.34

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.